Home / Pentamidine Isethionate / United States
US ATC P01CX01 · updated 2 Nov 2026
Pentamidine Isethionate shortage in United States
Is there a Pentamidine Isethionate shortage in United States?
Yes. As of 2 Nov 2026, 1 Pentamidine Isethionate product is reported short in United States, the first since 23 Mar 2026. No return date has been given. Main reason: not stated.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2) discontinuation | XGen Pharmaceuticals DJB, Inc. | 23 Mar 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).